Our Investments

Portfolio

Innovative companies that set 2Flo apart — investing in life sciences and healthcare solutions addressing unmet medical needs.

Vivacelle Bio

Vivacelle Bio leverages phospholipid nanoparticles treating relative (nitric oxide induced) and absolute hypovolemia due to septic or hemorrhagic shock.

Temprian Therapeutics

A biotech company focused on developing a safe and effective treatment for the skin depigmentation disease, Vitiligo.

Delphian Therapeutics

Delphian Therapeutics is a pioneer in FDA-approved, cannabinoid-based pain relief for hard-to-treat musculoskeletal and neurological conditions. Pain is commonly undertreated in patients of color and is shown to exacerbate adverse health outcomes.

ResQ Pharma

ResQ Pharma is a life sciences company seeking to reduce disparities in overdose deaths by improving access to easy-to-use antidotes for non-opiate drug overdoses.

KeyCare

KeyCare, the only virtual care platform built within Epic Systems, aims to eliminate systemic racial health gaps by improving access to safe, timely, and integrated medical care.

CancerIQ

CancerIQ is a cancer-focused precision health platform that empowers healthcare providers to detect cancer earlier and prevent it altogether across all patient populations.

Temprian Oncology

Temprian Oncology is an early stage biotechnology company developing low-cost, off-the-shelf, targeted treatments for metastatic melanoma that combine both chemo- and immuno-therapeutic effects.

Akan Biosciences

Akan Biosciences is focused on improving access to next-generation regenerative therapeutics for injuries and inflammatory diseases. Akan aims to reduce disparities by making stem cell-based therapy widely accessible to patients.

4D Healthware

4D Healthware is a digital health company providing enhanced telehealth solutions that reduce patient visits and improve access to care for underserved communities.

Have a Healthcare Innovation?

We invest in determined entrepreneurs addressing large unmet medical needs.

Pitch to Us